Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352.
Bleyer
Archie
A
Alberts
David S
DS
D004999:Amifostine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D018736:DNA Adducts; D062787:Drug Overdose / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008107:Liver Diseases / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013885:Thiosulfates / Q000494:pharmacology / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D002614:Chelating Agents; D018736:DNA Adducts; D011837:Radiation-Protective Agents; D013885:Thiosulfates; C017717:sodium thiosulfate; D004999:Amifostine; D002945:Cisplatin